State Street’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-222,576
Closed -$119K 4354
2024
Q4
$119K Buy
222,576
+16,100
+8% +$8.62K ﹤0.01% 3959
2024
Q3
$363K Hold
206,476
﹤0.01% 3656
2024
Q2
$242K Sell
206,476
-975,268
-83% -$1.14M ﹤0.01% 3765
2024
Q1
$10.7M Buy
1,181,744
+175,837
+17% +$1.59M ﹤0.01% 2545
2023
Q4
$10.9M Buy
1,005,907
+10,352
+1% +$113K ﹤0.01% 2539
2023
Q3
$8.01M Buy
995,555
+96,277
+11% +$775K ﹤0.01% 2703
2023
Q2
$9.77M Buy
899,278
+747,302
+492% +$8.12M ﹤0.01% 2658
2023
Q1
$1.05M Buy
151,976
+9,900
+7% +$68.3K ﹤0.01% 3524
2022
Q4
$565K Buy
142,076
+21,900
+18% +$87.2K ﹤0.01% 3726
2022
Q3
$799K Sell
120,176
-10,000
-8% -$66.5K ﹤0.01% 3647
2022
Q2
$630K Sell
130,176
-530,343
-80% -$2.57M ﹤0.01% 3748
2022
Q1
$6.18M Sell
660,519
-27,753
-4% -$259K ﹤0.01% 3078
2021
Q4
$8.18M Sell
688,272
-30,082
-4% -$357K ﹤0.01% 3016
2021
Q3
$8.18M Buy
718,354
+64,408
+10% +$733K ﹤0.01% 2993
2021
Q2
$11.7M Buy
653,946
+142,996
+28% +$2.57M ﹤0.01% 2822
2021
Q1
$7.91M Sell
510,950
-111,957
-18% -$1.73M ﹤0.01% 2845
2020
Q4
$7.6M Buy
622,907
+239,612
+63% +$2.92M ﹤0.01% 2772
2020
Q3
$4.93M Buy
383,295
+3,323
+0.9% +$42.7K ﹤0.01% 2796
2020
Q2
$3.86M Buy
379,972
+75,560
+25% +$768K ﹤0.01% 2892
2020
Q1
$2.47M Buy
304,412
+75,447
+33% +$613K ﹤0.01% 2963
2019
Q4
$1.98M Sell
228,965
-3,893
-2% -$33.6K ﹤0.01% 3257
2019
Q3
$1.43M Buy
232,858
+10,856
+5% +$66.9K ﹤0.01% 3324
2019
Q2
$3.69M Buy
222,002
+43,921
+25% +$729K ﹤0.01% 2984
2019
Q1
$2.98M Buy
178,081
+30,064
+20% +$503K ﹤0.01% 2994
2018
Q4
$1.7M Buy
148,017
+2,593
+2% +$29.8K ﹤0.01% 3177
2018
Q3
$5.82M Buy
145,424
+7,730
+6% +$309K ﹤0.01% 2787
2018
Q2
$3.89M Buy
137,694
+127,189
+1,211% +$3.6M ﹤0.01% 2985
2018
Q1
$160K Buy
10,505
+1,936
+23% +$29.5K ﹤0.01% 3579
2017
Q4
$279K Sell
8,569
-1,456
-15% -$47.4K ﹤0.01% 3532
2017
Q3
$235K Buy
+10,025
New +$235K ﹤0.01% 3583